Breslau, Rachel Milstein http://orcid.org/0000-0003-1624-7676
Cohen, Joshua T. http://orcid.org/0000-0003-1737-0991
Ollendorf, Daniel A. http://orcid.org/0000-0001-6016-8129
Neumann, Peter J. http://orcid.org/0000-0003-1226-4073
Article History
Accepted: 12 July 2022
First Online: 23 July 2022
Declarations
:
: This work received no external funding.
: The Center for the Evaluation of Value and Risk in Health, which employs Rachel Breslau, Joshua Cohen, Daniel Ollendorf, and Peter Neumann, receives sponsorship funding from government agencies, nonprofit institutions, and drug and device manufacturers, to support research projects and to maintain and update multiple databases. Joshua Cohen, Daniel Ollendorf, and Peter Neumann receive consulting income from companies in the life sciences industry. Daniel Ollendorf is a former employee of ICER and receives grant funding from that organization for participation in assessments of new and emerging health technologies. Neither funding from ICER nor sponsorship fees supported the analyses described in this article.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated and analyzed for the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study conception and design. RB collected data and all authors contributed to the data analysis. RB wrote the first draft of the manuscript and all authors revised the manuscript. All authors read and approved the final manuscript.